Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 14 September 2018, 13:31 HKT/SGT
Share:
    

Source: Hitachi, Ltd.
Hitachi's First Dedicated Compact Proton Therapy System to be Supplied to Tokushukai Medical Group
System will be Installed at Shonan Kamakura Advanced Medical Center, Scheduled to be Complete in September 2020

TOKYO, Sept 14, 2018 - (JCN Newswire) - Hitachi, Ltd. (TSE: 6501) announced today that it has received an order for the compact proton therapy system from Tokushukai Medical Group, and the system will be installed at Shonan Kamakura Advanced Medical Center, which is planned to be built near Shonan Kamakura General Hospital. This is the first order for Hitachi's dedicated compact proton therapy system.

Following the expansion of demand for proton therapy system with minimized footprint worldwide, Hitachi has developed dedicated single room proton therapy system (Single Room Solution). Single Room Solution features optimized system configuration, reducing the footprint to 70% of conventional solution, realizing installation in urban limited areas and contributing to lower the initial cost and shorten the lead time. Other features include spot scanning technology for treating certain forms of cancer and full rotating gantry with cone beam CT for precise patient positioning, sustaining high performance technologies in minimized footprint.

Tokushukai Medical Group, operating 339 medical facilities in Japan, is planning to build Shonan Kamakura Advanced Medical Center near Shonan Kamakura General Hospital, targeting to complete in September 2020. Four-story building with one basement floor will be comprehensive center for proton therapy, BNCT (Boron Neutron Capture Therapy), RI (Radioisotope) therapy and drug discovery research and support through the use of PET (Positron Emission Tomography).

Hitachi has been proactively promoting particle therapy business worldwide, supplying world-class facilities around the world with its highly reliable and proven particle therapy systems, which have treated more than 16,000 patients, and integrating Mitsubishi Electric Corporation's particle therapy system business in June 2018. Under the new organization, Hitachi will provide products and services with higher performance and added value, including Single Room Solution and hybrid system combined with capability of proton and heavy ion therapy.

As Hitachi expands its healthcare business, it will continue to accelerate the globalization of its particle therapy system business and contribute to cancer treatment around the world.

Single Room Solution will be introduced at the American Society for Radiation Oncology (ASTRO) Annual Meeting to be held in San Antonio from October 21, 2018.

Overview of Particle Therapy

Particle Therapy is an advanced type of cancer radiotherapy. Protons extracted from hydrogen atoms, or carbon ions are accelerated up to 70% of the speed of light. This energy is concentrated directly on the tumor while minimizing radiation dose to surrounding healthy tissue. Particle therapy improves the quality of life for cancer patients since the patient experiences no pain during treatment and the procedure has very few side effects compared to that of traditional radiotherapy. In most cases, patients can continue with their normal daily activities while undergoing treatment.


About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society's challenges, combining its operational technology, information technology, and products/systems. The company's consolidated revenues for fiscal 2017 (ended March 31, 2018) totaled 9,368.6 billion yen ($88.4 billion). The Hitachi Group is an innovation partner for the IoT era, and it has approximately 307,000 employees worldwide. Through collaborative creation with customers, Hitachi is deploying Social Innovation Business using digital technologies in a broad range of sectors, including Power/Energy, Industry/Distribution/Water, Urban Development, and Finance/Social Infrastructure/Healthcare. For more information on Hitachi, please visit the company's website at http://www.hitachi.com.

Contact:
Hitachi Ltd
Corporate Communications
Tel: +81-3-3258-1111


Sept 14, 2018 13:31 HKT/SGT
Source: Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501)

Topic: Press release summary
Sectors: Electronics, BioTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2018 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


Hitachi, Ltd. Links

http://www.hitachi.com

https://www.facebook.com/hitachi.global/

https://twitter.com/hitachiglobal?lang=en

https://www.youtube.com/user/HitachiBrandChannel

https://ph.linkedin.com/company/hitachi

Hitachi, Ltd.
Nov 14, 2018 20:06 HKT/SGT
MOU signed by Changhua County Government and Hitachi, Ltd. and Agreed to Use Changhua Port for Operation and Maintenance of Changhua Offshore Wind Farm
Oct 31, 2018 16:14 HKT/SGT
Suntory Beverage & Food and Hitachi Develop Production Planning System Utilizing AI through Collaborative Creation
Oct 31, 2018 11:17 HKT/SGT
Hitachi: Demonstration Project in Germany, Large-Scale Hybrid Power Storage System Starting to Operate in November
Oct 29, 2018 18:47 HKT/SGT
Hitachi to Increase Stake in Ansaldo STS
Oct 29, 2018 15:00 HKT/SGT
Hitachi and SBI Enter into Joint Venture to Accelerate Digital Payments in India
Oct 26, 2018 08:55 HKT/SGT
Hitachi Announces Reorganization of Industrial Equipment Business through Company Split
Oct 23, 2018 09:22 HKT/SGT
Hitachi Appoints Partners to Support Wylfa Newydd
Oct 22, 2018 06:45 HKT/SGT
Demonstration of Hitachi ICT System verifies Efficiencies in Energy and Medical IT Operations at New Delhi AIIMS Hospital
Oct 16, 2018 13:43 HKT/SGT
Hitachi's Heavy Ion Beam Therapy System Starts Treatment at Osaka Heavy Ion Therapy Center
Oct 12, 2018 14:00 HKT/SGT
Daikin and Hitachi Start Joint Demonstration Aiming to Digitalize Quality Control Know-How in Reaction Process of Chemical Manufacturing
More news >>
 News Alerts
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6721 7212

Connect With us: